Metabolic Disorders
DURECT concludes patient enrolment in Phase IIb trial of AH therapy
DURECT has concluded the enrolment of patients in the Phase IIb clinical trial of larsucosterol for the treatment of severe…
Synlogic begins Phase III trial of SYNB1934 for phenylketonuria
US-based biotechnology firm Synlogic has begun a Phase III trial of SYNB1934 for the treatment of phenylketonuria (PKU), a rare…
Pipeline Moves: Novo Nordisk Phase III semaglutide completion bumps approval prospects
This week on Pipeline Moves, we start the week by looking at the completion of the Phase III trial investigating…
Novo Nordisk’s trial of oral semaglutide meets primary endpoint
Danish pharmaceutical company Novo Nordisk has reported positive results from the OASIS 1 Phase IIIa clinical trial of oral semaglutide…
Moderna reports interim data of mRNA therapy for propionic acidemia
Moderna has reported interim data from a Phase I/II clinical trial of its investigational mRNA therapy, mRNA-3927, for the treatment…
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
HTIT concludes Phase III trial of oral insulin for type 2 diabetes
Hefei Tianhui Biotechnology (HTIT), a strategic partner of Oramed Pharmaceuticals, has completed its Phase III trials of oral insulin for…
Boan Biotech completes patient enrolment in trial of type 2 diabetes
Boan Biotech has completed the enrolment of patients in China in its Phase III clinical trial of Dulaglutide Injection (BA5101)…
First Wave completes patient screening in trial of cystic fibrosis therapy
First Wave BioPharma has completed patient screening in its ongoing Phase II SPAN clinical trial of adrulipase for the treatment…
Boehringer and Zealand’s BI 456906 trial meets primary endpoint
Boehringer Ingelheim and Zealand Pharma’s Phase II clinical trial evaluating the effect of different doses of BI 456906 in patients…
Innovent’s Phase ll mazdutide trial achieves 24-week primary endpoint
Innovent Biologics has reported that its Phase ll trial of a higher dose of 9mg mazdutide (IBI362) to treat Chinese…